WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.09%)Nav, as on 30-04-2025

  • Previous Nav

  • Net Change on 30-04-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 15.44 20.01 22.50 1.82 8,080.97
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 20.77 24.16 25.01 1.94 4,914.64
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 20.63 23.83 24.41 1.94 3,610.51
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 14.19 19.75 23.89 1.93 3,018.76
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 16.95 18.40 22.23 1.96 2,667.40

Fund Holdings as on 31-March-2025

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Divi's Laboratories Limited

  • Lupin Limited

  • Max Healthcare Institute Limited

  • Torrent Pharmaceuticals Limited

  • Krishna Institute Of Medical Sciences Limited

  • Fortis Healthcare Limited

  • Laurus Labs Limited

  • Piramal Pharma Limited

  • Net Receivables / (Payables)

  • IPCA Laboratories Limited

  • Apollo Hospitals Enterprise Limited

  • Ajanta Pharma Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Abbott India Limited

  • Clearing Corporation of India Ltd

  • Biocon Limited

  • Poly Medicure Limited

  • Neuland Laboratories Limited

  • Global Health Limited

  • Jupiter Life Line Hospitals Limited

  • Rainbow Childrens Medicare Limited

  • Kovai Medical Center and Hospital Limited

  • Eris Lifesciences Limited

  • Supriya Lifescience Limited

  • Alembic Pharmaceuticals Limited

  • Ami Organics Limited

  • Vijaya Diagnostic Centre Limited

  • Mankind Pharma Limited

  • Strides Pharma Science Limited

  • AstraZeneca Pharma India Limited

  • 91 Days Tbill (MD 08/05/2025)

  • Thyrocare Technologies Limited

  • Shaily Engineering Plastics Limited

  • Sai Life Sciences Limited

  • Laxmi Dental Limited

  • RPG Life Sciences Limited

  • Navin Fluorine International Limited

  • Blue Jet Healthcare Ltd

  • 364 Days Tbill (MD 23/05/2025)

  • Emcure Pharmaceuticals Limited

  • Dr.Agarwals Eye Hospital Limited

  • PB Fintech Limited

  • Jubilant Ingrevia Limited

  • Alkyl Amines Chemicals Limited

  • 91 Days Tbill (MD 10/04/2025)

  • 91 Days Tbill (MD 17/04/2025)

  • Zota Health Care Limited

  • 91 Days Tbill (MD 24/04/2025)

  • 182 Days Tbill (MD 05/06/2025)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

  • Chemicals

  • Plastic Products

  • Fintech

View More

Fund Manager

  • Cash

  • Equity

  • Sovereign

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹303.62 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended down ₹-0.01(-0.09%)yesterday to ₹12.864.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643